Occurrence of vitiligo in a patient with ankylosing spondylitis receiving adalimumab

被引：8
|
作者：
Toussirot, E. [1 ,2 ,3 ,4 ]
Salard, D. [5 ]
Algros, M. -P. [6 ]
Aubin, F. [7 ,8 ]
机构：
[1] CHRU, Ctr Invest Clin Biotherapie, Pole Rech, Inserm CBT 506, F-25000 Besancon, France
[2] Hop Jean Minjoz, CHRU, Pole PACTE, F-25000 Besancon, France
[3] Univ Franche Comte, Dept Univ Therapeut, F-25000 Besancon, France
[4] Univ Franche Comte, UPRES EA Agents Pathogenes & Inflammat 4266, SFR FED 4234, F-25000 Besancon, France
[5] Ctr Hosp, Serv Med 1, F-25300 Pontarlier, France
[6] Hop Jean Minjoz, CHRU, Serv Anat Pathol, F-25030 Besancon, France
[7] Hop Jean Minjoz, CHRU, Serv Dermatol, F-25030 Besancon, France
[8] Univ Franche Comte, Equipe Accueil EA3181, SFR FED 4234, F-25000 Besancon, France
来源：
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2013年 / 140卷 / 12期
关键词：
NECROSIS-FACTOR-ALPHA;
D O I：
10.1016/j.annder.2013.09.158
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：801 / 802
页数：2
相关论文
共 50 条
  • [1] Cryptosporidiosis in a patient with ankylosing spondylitis treated with adalimumab
    Chiuchetta, Fernando Augusto
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2010, 50 (03) : 330 - 332
  • [2] Vitiligo improvement in a patient with Ankylosing spondylitis treated with infliximab
    Simon, J. -Abraham
    Burgos-Vargas, Ruben
    DERMATOLOGY, 2008, 216 (03) : 234 - 235
  • [3] The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis
    Slobodin, Gleb
    Rosner, Itzhak
    Rimar, Doron
    Boulman, Nina
    Rozenbaum, Michael
    Odeh, Majed
    CLINICAL RHEUMATOLOGY, 2010, 29 (07) : 793 - 794
  • [4] Cutaneous leishmaniasis in a patient with ankylosing spondylitis using adalimumab
    Poti Gomes, Kirla Wagner
    Benevides, Andre Nunes
    Fernandes Vieira, Francisco Jose
    de Morais Burlamaqui, Maggy Poti
    de Almeida e Pontes Vieira, Marcos
    Adeodato Ramos Fontenelle, Lysiane Maria
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2012, 52 (03) : 447 - 452
  • [5] The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis
    Gleb Slobodin
    Itzhak Rosner
    Doron Rimar
    Nina Boulman
    Michael Rozenbaum
    Majed Odeh
    Clinical Rheumatology, 2010, 29 : 793 - 794
  • [6] Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab
    Azevedo, V. F.
    Paiva, E.
    Tosin, T.
    Ferreira, A.
    Ferreira, A. M.
    Fernandes, M.
    REUMATISMO, 2011, 63 (03) : 171 - 174
  • [7] Tuberculous myositis in a patient with ankylosing spondylitis treated with adalimumab
    Azevedo, Valderilio Feijo
    Parchen, C.
    Coelho, S. A.
    Lacerda, D. C.
    Hirth, C. G.
    RHEUMATOLOGY INTERNATIONAL, 2009, 29 (11) : 1381 - 1384
  • [8] A Case of Hepatic Tuberculosis in a Patient on Adalimumab for Ankylosing Spondylitis
    Amini, Shayan
    Allencherril, Ronan
    Lin, Michelle
    Crumley, Suzanne M.
    Victor, David W.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [9] Tuberculous myositis in a patient with ankylosing spondylitis treated with adalimumab
    Valdeŕilio Feijó Azevedo
    C. Parchen
    S. A. Coelho
    D. C. Lacerda
    C. G. Hirth
    Rheumatology International, 2009, 29
  • [10] Adalimumab for the treatment of ankylosing spondylitis
    Sieper, Joachim
    Rudwaleit, Martin
    Braun, Juergen
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (06) : 831 - 838
12345